 |
Superoxide dismutase (human) |
|---|---|
| Trade Name | |
| Orphan Indication | For protection of donor organ tissue from damage or injury mediated by oxygen-derived free radicals that are generated during the necessary periods of ischemia (hypoxia, anoxia), and especially reperfusion, associated with the operative procedure |
| USA Market Approval | USA |
| USA Designation Date | 1985-03-06 00:00:00 |
| Sponsor | Pharmacia-Chiron Partnership;4560 Horton Street;Emeryville, California, 94608 |
